ClinicalTrials.Veeva

Menu

Functional Electrostimulation on the Upper Lip in Multiple Sclerosis (EM/2024)

U

Universidad de Burgos

Status

Not yet enrolling

Conditions

Therapy
Directly Observed Therapy
Electrode Site Reaction

Treatments

Other: GLOBUS ELITE
Other: Fesia Grasp

Study type

Interventional

Funder types

Other

Identifiers

NCT06638775
COPTOCYL/2025
IO/102025 (Other Identifier)

Details and patient eligibility

About

Multiple sclerosis (MS) is an autoimmune disease where immune cells attack the body, triggering an inflammatory response. A study comparing multifield FES and conventional FES on upper extremity motor skills and functional independence in MS patients will be conducted. Results suggest that both types of FES treatments normalize muscle tone, showing superior results compared to those without FES therapy. The study aims to compare the effects of both types on MS patients.

Full description

Multiple sclerosis (MS) is an autoimmune disease in which cells of the immune system attack the body itself. This condition generates an activation of the immune system that triggers an inflammatory response. General objective: To compare the effect of multifield FES and conventional FES on upper extremity motor skills and functional independence in people with MS. Methodology: A three-arm prospective longitudinal multicenter randomized controlled trial (RCT) will be conducted: conventional therapy (Control Group, CG), an experimental group 1 (EG1) which in addition to this same treatment will use the conventional FES tool, through the Globus Elite device, and an experimental group 2 (EG2) which will differ from GE1 in that it will use the FES multi-field device through FESIA Grasp. Results: It is expected that people who have used any type of FES will have a more normalized muscle tone compared to those who have not received this type of treatment. The research compares the effects of two types of FES in people with multiple sclerosis, focusing on improved motor skills and functional independence. Both FES treatments are expected to normalize muscle tone, showing superior results compared to those who do not receive this therapy.

Enrollment

30 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Be of legal age and sign the informed consent form.
  • Not suffer from any pathology in the upper limb such as tendinitis, oedema, fractures, etc.
  • Intact skin (no breaks, scratches, cuts, and other superficial or deep injuries) on the arm where the devices will be placed if applicable

Exclusion criteria

  • Severe medical problems.
  • Use of a pacemaker.
  • Pregnancy.
  • Cutaneous neuropathies.
  • Presence of other neuromuscular pathologies.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

30 participants in 2 patient groups

EXPERIMENTAL GROUP
Experimental group
Description:
The Fesia Grasp device is based on the superficial electrical stimulation of the forearm musculature to provoke flexion and extension movements of the wrist, thumb, index finger and fingers 3, 4 and 5.
Treatment:
Other: Fesia Grasp
CONTROL GROUP
Experimental group
Description:
Globus elite intervention: is an electro-stimulator designed for sport and fitness, but with special attention also for beauty treatments thanks to the new sequential stimulation currents, excellent for their draining effects.
Treatment:
Other: GLOBUS ELITE

Trial contacts and locations

0

Loading...

Central trial contact

Olalla Saiz Vazquez, phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems